Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-12-17

FDA Approved: BYSTOLIC — Original Application (Allergan, Inc.)

View source ↗

Summary

This FDA original approval documents the approval of BYSTOLIC (nebivolol hydrochloride) by Allergan, Inc. for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYSTOLIC (nebivolol hydrochloride)

Snippet

ORIG AP for BYSTOLIC (NEBIVOLOL HYDROCHLORIDE)